2021
Management of Pediatric Graves Disease
Quintanilla-Dieck L, Khalatbari HK, Dinauer CA, Rastatter JC, Chelius DC, Katowitz WR, Shindo ML, Parisi MT, Kazahaya K. Management of Pediatric Graves Disease. JAMA Otolaryngology - Head & Neck Surgery 2021, 147: 1110-1118. PMID: 34647991, DOI: 10.1001/jamaoto.2021.2715.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsGraves' diseaseClinical presenting signsPediatric Graves' diseaseSustained remission rateRadioactive iodine therapyFirst-line treatmentSpecific clinical characteristicsMultidisciplinary approachIodine therapyRemission rateClinical characteristicsDefinitive treatmentMedical therapyPediatric patientsPresenting signMedical managementPediatric populationAntithyroid drugsTherapeutic optionsCertain patientsTreatment optionsOptimal treatmentThyroid ultrasonographyPediatric expertsNuclear medicine
2010
Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children
Rivkees SA, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. PMID: 20224800, PMCID: PMC2833412, DOI: 10.1155/2010/176970.Peer-Reviewed Original ResearchAdverse eventsGraves' diseaseSide effectsGraves' disease therapyWeeks of therapyStevens-Johnson syndromeCommon side effectsConsecutive pediatric patientsMajor side effectsDisease therapyAverage daily doseAntithyroid medicationDiffuse arthralgiaMethimazole therapyMMI useCholestatic jaundiceJoint painPatient ageDaily dosePediatric patientsPediatric populationCommon causePatientsMedicationsDisease
2009
Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children
Rivkees S, Dinauer C. Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children. 2009, 942-955. DOI: 10.1016/b978-0-12-374135-6.00098-4.ChaptersGraves' diseaseRadioactive iodineThyroid cancerSide effectsLong-term adverse side effectsLong-term remission ratesRecurrent laryngeal nerve paresisPreferred definitive treatmentTreatment of GravesAcute side effectsBone marrow suppressionLaryngeal nerve paresisLong-term complicationsSerious adverse reactionsCurrent treatment optionsHigh cure ratesLarge thyroid glandForm of surgeryAdverse side effectsGenetic damageAntithyroid medicationDefinitive therapyNerve paresisPermanent hypoparathyroidismRemission rate
2007
An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine
Rivkees SA, Dinauer C. An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine. The Journal Of Clinical Endocrinology & Metabolism 2007, 92: 797-800. PMID: 17341574, DOI: 10.1210/jc.2006-1239.Commentaries, Editorials and LettersConceptsGraves' diseaseAntithyroid medicationRadioactive iodineThyroid cancerSide effectsLong-term adverse side effectsPediatric Graves' diseaseAcute side effectsLong-term remissionTreatment of hyperthyroidismAdverse side effectsMajority of childrenCurative therapyThyroid irradiationPediatric populationSpontaneous remissionOptimal treatmentSufficient dosesDefinite riskTreatment approachesMedicationsEffective cureDiseaseRemissionChildren